Endothelin receptor antagonist (unspecified)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Endothelin receptor antagonist (unspecified), covering 2012-06-12 to 2024-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm [Phase 2, Phase 3]